Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

REV1: A novel biomarker and potential therapeutic target for various cancers

29 Sept 2022

Abstract excerpt

Background: REV1 is a member of the translesion synthesis DNA polymerase Y family. It is an essential player in a variety of DNA replication activities, and perform major roles in the production of both spontaneous and DNA damage-induced mutations. This study aimed to explore the role of REV1 as a prognostic biomarker and its potential function regulating the sensitivity of anti-tumor drugs in various cancers....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Genetic factors in colorectal cancer
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36246647
DOI: 10.3389/fgene.2022.997970

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

REV1: A novel biomarker and potential therapeutic target for various cancersPMID 36246647Read ↗

REV7 in Cancer Biology and ManagementSemantic proximity Read ↗

REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axisSemantic proximity Read ↗

Rev1-Rev7 Complex Inhibitor JH-RE-06 Enhances Mitomycin C Chemosensitivity in HCT116 Colorectal Cancer CellsSemantic proximity Read ↗

REV1 Inhibition Enhances Radioresistance and AutophagySemantic proximity Read ↗

Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress toleranceSemantic proximity Read ↗

REV1 Inhibition Enhances Radioresistance and AutophagySemantic proximity Read ↗

PharmGKB summary: very important pharmacogene information for MT-RNR1.Semantic proximity Read ↗

Prospects of POLD1 in Human Cancers: A ReviewSemantic proximity Read ↗

Rev1 overexpression accelerates N-methyl-N-nitrosourea (MNU)-induced thymic lymphoma by increasing mutagenesis.Semantic proximity Read ↗

DNA polymerase eta: A potential pharmacological target for cancer therapySemantic proximity Read ↗

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesisSemantic proximity Read ↗

Long Noncoding RNA KCNQ1OT1 is a Prognostic Biomarker and mediates CD8+ T cell exhaustion by regulating CD155 Expression in Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.